Da Cunha AP et al. found that the administration of anti-LAP resulted in a significant reduction of the number of CD4+LAP+ T cells that populate the spleen and mesenteric lymph nodes, with no effect over the CD4+Foxp3+ T cell population in experimental autoimmune encephalomyelitis model. The gene discussed is CD4; the disease is experimental autoimmune encephalomyelitis.